CollPlant Biotechnologies Analyst Price Targets

Wall Street analyst price targets and consensus rating for CollPlant Biotechnologies (CLGN).

Price Target Range — 8 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$125Upside to Avg. PT+2867.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Feb 6, 2026	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Nov 28, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$120
Oct 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$120
Sep 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$120
Aug 21, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110
Aug 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$120
May 30, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$120
May 28, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$140→$120
Mar 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$140
Feb 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$140
Feb 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$140
Nov 29, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110
Nov 27, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$140
Aug 21, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110
Aug 20, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$140
Aug 5, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$140
May 30, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110
Apr 5, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110
Nov 30, 2023	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$110

Analyst Ratings News

This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

Avi Kapoor

PRO
D. Boral Capital Downgrades CollPlant Biotechnologies to Hold

D. Boral Capital analyst Jason Kolbert downgrades CollPlant Biotechnologies (NASDAQ:CLGN) from Buy to Hold.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.

Benzinga Newsdesk

Analyst Expectations For CollPlant Biotechnologies's Future

Benzinga Insights

CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

PRO
D. Boral Capital Downgrades CollPlant Biotechnologies to Hold

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

Analyst Expectations For CollPlant Biotechnologies's Future

People Also Watch

People Also Watch

CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

PROD. Boral Capital Downgrades CollPlant Biotechnologies to Hold

PROD. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PROD. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PROD. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

Analyst Expectations For CollPlant Biotechnologies's Future

People Also Watch

People Also Watch

PRO
D. Boral Capital Downgrades CollPlant Biotechnologies to Hold

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

PRO
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target